TY  - CONF

T1  - Integrated Analysis of Abrocitinib for the Treatment of Adolescents with Moderate-to-Severe Atopic Dermatitis From the Phase 3 Clinical Trial Program

JO  - JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

PY  - 2023/01/01

AU  - Paller A

AU  - Eichenfield LF

AU  - Cork MJ

AU  - Bangert C

AU  - Irvine AD

AU  - Weidinger S

AU  - Johnson S

AU  - Lazariciu I

AU  - Koppensteiner H

ED  - 

VL  - 21

SP  - 77

EP  - 77

Y2  - 2024/12/22

ER  -